Literature DB >> 10799850

Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes.

E J Goetzl1, Y Kong, J K Voice.   

Abstract

Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) from platelets and macrophages mediate T cell functions. Endothelial differentiation gene-encoded G protein-coupled receptors (Edg Rs) are specific for S1P (Edg-1, -3, -5, and -8 Rs) and LPA (Edg-2, -4, and -7 Rs). Human T cell tumors express many Edg Rs for both LPA and S1P. In contrast, human blood CD4+ T cells express predominantly Edg-4, and CD8+ T cells show only traces of Edg-2 and -5, by quantification of mRNA and Edg R Ags. LPA at 10-10-10-6 M suppressed significantly the secretion of IL-2 from anti-CD3 plus anti-CD28 Ab-challenged CD4+ T cells, but not CD8+ T cells. Monoclonal anti-Edg-4 R Ab, like LPA, suppressed stimulated IL-2 secretion from CD4+ T cells, but not CD8+ T cells. Constitutive expression of Edg-4 by CD4+, but not CD8+, human T cells accounts for differential functional responsiveness of the T cell subsets to LPA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799850     DOI: 10.4049/jimmunol.164.10.4996

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Authors:  Shannon K Oda; Pamela Strauch; Yuko Fujiwara; Amin Al-Shami; Tamas Oravecz; Gabor Tigyi; Roberta Pelanda; Raul M Torres
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

3.  Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.

Authors:  Long Shuang Huang; Panfeng Fu; Priya Patel; Anantha Harijith; Tianjiao Sun; Yutong Zhao; Joe G N Garcia; Jerold Chun; Viswanathan Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

Review 4.  The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.

Authors:  Seung-Jae Kim; Hyung-Geun Moon; Gye Young Park
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-29       Impact factor: 4.698

Review 5.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

6.  Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis.

Authors:  Songbai Lin; Yiran Han; Kayte Jenkin; Sei-Jung Lee; Maiko Sasaki; Jan-Michael Klapproth; Peijian He; C Chris Yun
Journal:  Am J Pathol       Date:  2017-11-09       Impact factor: 4.307

Review 7.  Lysophosphatidic acid signalling in development.

Authors:  Xiaoyan Sheng; Yun C Yung; Allison Chen; Jerold Chun
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

Review 8.  Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system.

Authors:  Edward J Goetzl; Wengang Wang; Christine McGiffert; Mei-Chuan Huang; Markus H Gräler
Journal:  J Cell Biochem       Date:  2004-08-15       Impact factor: 4.429

Review 9.  Lysophosphatidic acid and autotaxin: emerging roles in innate and adaptive immunity.

Authors:  Steve N Georas
Journal:  Immunol Res       Date:  2009-01-30       Impact factor: 2.829

Review 10.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.